Tech Company CollectionsBiotechnology Companies
List of Biotechnology Companies
or search all companiesSelect...
Select...
Loading...
Page 1 of NaN
Displaying companies
Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven histo | San Francisco | CA | 5 - 10 | 2025 | $120,000,000 |
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lys | San Francisco | CA | 10 - 50 | 2025 | $200,000,000 |
GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external inve | 10 - 50 | 2024 | $300,000,000 | ||
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) spec | Wilmington | DE | 10 - 50 | 2024 | $5,500,000 |
Developing innovative therapeutics to materially improve the lives of patients. We strive to be transparent and open in our goals, plans, and progress. | San Diego | CA | 5 - 20 | 2024 | $370,000,000 |
Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. | Waltham | MA | 10 - 50 | 2024 | $400,000,000 |
Chai Discovery creates Chai-1, a multi-modal foundation model designed for predicting molecular structures relevant to drug discovery. The model facilitates the unified prediction of proteins, small molecules, and nucleic acids, and is available for free f | San Francisco | CA | 2 - 10 | 2024 | $30,000,000 |
GEMMABio is a therapeutics company that supports the rare disease community. | Philadelphia | PA | 50 - 200 | 2024 | $34,000,000 |
Navigator Medicines operate as a biotech company that leads the advancement of biologics for targeted immune regulation & restoration. | Scotch Plains | NJ | 2 - 10 | 2024 | $100,000,000 |
Jupiter Endovascular is a medical technology start-up. Its mission is to cover the entire spectrum of cardiovascular illness, seeing compelling potential to reinvent treatments for millions of people. | Menlo Park | CA | 10 - 50 | 2024 | $21,000,000 |
K-Scale Labs is a robotic engineering company specializing in creating open-source humanoid robots. | New York | NY | 2 - 10 | 2024 | $500,000 |
Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. | 10 - 50 | 2024 | $60,251,248 | ||
Nura Health is a molecular diagnostics company whose mission is to advance women's health through the development and delivery of novel practice-changing non-invasive tests. We prioritize innovative, evidence-based diagnostic methods enhanced by AI & Machi | Irvine | CA | 5 - 10 | 2024 | $3,000,000 |
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | 10 - 50 | 2024 | $105,000,000 | ||
VisiRose offers an innovative approach to treating infectious keratitis and other eye diseases. | Knoxville | TN | 1 - 10 | 2024 | $3,000,000 |
Seaport Therapeutics operates as a clinical stage biopharmaceutical company. | Boston | MA | 10 - 50 | 2024 | $325,000,000 |
nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques. | Boston | MA | 50 - 100 | 2024 | $75,000,000 |
Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines. | 10 - 50 | 2024 | $93,500,000 | ||
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders. | Boulder | CO | 10 - 50 | 2024 | $41,000,000 |
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end | San Francisco | CA | 50 - 100 | 2024 | $1,000,000,000 |
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses. | South San Francisco | CA | 10 - 50 | 2024 | $101,000,000 |
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on pro | San Diego | CA | 10 - 50 | 2024 | $180,000,000 |
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the str | Boston | MA | 10 - 50 | 2024 | $100,000,000 |
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates to deliver best-in-class therapeutics and focused on rapidly advancing next generation transformative assets. | San Francisco | CA | 2 - 10 | 2024 | $92,000,000 |
Cradle is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies. | San Francisco | CA | 10 - 50 | 2024 | $48,000,000 |
Mirador Therapeutics envisions precision medicine for immune-mediated inflammatory and fibrotic diseases. | San Diego | CA | 20 - 50 | 2024 | $480,000,000 |
Primrose Bio is a biotech company that focuses on discovery, development, and manufacturing of new molecules. innovative therapeutics, vaccines and ingredients to aevance global health. | San Diego | CA | 50 - 100 | 2023 | $14,999,999 |
Taxa is a synthetic microbiome company sculpting the skin microbiome using genetic engineering technologies such as CRISPR/spCas9. | San Francisco | CA | 2 - 10 | 2023 | $2,500,000 |
Granza Bio is a company that developing cancer therapies based on human body's immune system. | San Francisco | CA | 2 - 10 | 2023 | $7,640,000 |
Brightstar Therapeutics is a biotechnology company focused on innovative treatment options that improve clinical outcomes and quality of life for people living with corneal and ocular surface diseases. | Lexington | KY | 5 - 10 | 2023 | |
Eris Biotech is a biotech company that developing hypoxia-activated prodrugs (HAPs) for the treatment of solid tumors. | American Fork | UT | 2 - 10 | 2023 | $500,000 |
Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases. | 2 - 10 | 2023 | $15,000,000 | ||
We are Montara Therapeutics, a San Francisco-based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory | San Francisco | CA | 10 - 50 | 2023 | $28,000,000 |
About HAPPY POTATO - Perfect Fries ! The world's best Flavored French Fries ! Feel the Flavor with everyone's favorite French fries Products Flavoring Perfect Fries | 2 - 10 | 2023 | $5,575,000 | ||
Avenue Biosciences is pioneering the future of biotechnology, with a mission to transform the development of protein biologics for healthcare advancements. Our cutting-edge, high-throughput engineering platform transforms the production of protein biologic | Palo Alto | CA | 10 - 50 | 2023 | $2,500,000 |
Nanograb is a computational drug discovery company that uses AI to generate the best combination of binders to treat different diseases. | San Francisco | CA | 5 - 10 | 2023 | $500,000 |
ParcelBio is a company that creating a programmable method for safely and precisely delivering mRNA to many cell types in the body. | San Francisco | CA | 2 - 10 | 2023 | $500,000 |
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, | Fremont | CA | 20 - 50 | 2023 | $255,000,000 |
DANNCE is a deep learning solution to automate behavioral analysis for drug development and disease diagnosis. Our platform takes patient video as input and uses our proprietary 3-D pose tracking and behavioral analysis algorithms to quantify behavior. DA | Boston | MA | 2 - 10 | 2023 | $2,600,000 |
Peregrine Health is a healthcare company formed by Integrative Life Network (ILN) and Integrative Health Centers. | Nashville | TN | 20 - 50 | 2023 | $13,514,671 |
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch | Bedford | MA | 2 - 10 | 2023 | $20,000,000 |
Biostate AI develops generative AI that benefit all human health. | Palo Alto | CA | 10 - 50 | 2023 | $4,000,000 |
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease. | San Francisco | CA | 65 | 2023 | $826,000,000 |
Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolo | Brookline | MA | 2 - 10 | 2023 | $20,000,000 |
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drugs derived from placental tissue and consistently delivers a host of beneficial growth factors with potent anti-inflammatory, tissue-protective, and | Chapel Hill | NC | 2 - 10 | 2023 | $11,000,000 |
Caladan Bio specializes in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. | New York | NY | 2 - 10 | 2023 | $5,100,000 |
EvolutionaryScale is a developer of biological artificial intelligence models for therapeutic design. The business predicts protein structures by combining biological data from DNA sequences, gene expression, and epigenetic states, allowing scientists to u | New York | NY | 10 - 50 | 2023 | $142,000,000 |
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies . | Los Angeles | CA | 5 - 20 | 2023 | $30,000,000 |
Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages. | Boston | MA | 2 - 10 | 2023 | $5,200,000 |
Velorum Therapeutics produces powerful cancer treatments that starve tumors. | South San Francisco | CA | 2 - 10 | 2023 | $500,000 |
CrossBridge Bio operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology. | 2 - 10 | 2023 | $10,000,000 | ||
Mach5 Therapeutics is a biotechnology company. | Atlanta | GA | 1 - 10 | 2023 | $23,354,508 |
Pranax is a software company currently based in Pinehurst, Texas, United States. It has been founded in 2023. | Pinehurst | TX | 1 - 10 | 2023 | $10,000,000 |
Amplifyer Bio is a biotechnology research company that develops technology of transformative potential for the liquid biopsy field. | Lexington | MA | 1 - 10 | 2023 | $7,078,494 |
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services. | Somerville | MA | 1 - 10 | 2023 | $500,000 |
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical trials. In these stu | Falls Church | VA | 1 - 10 | 2023 | $10,400,000 |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors. | Palo Alto | CA | 1 - 10 | 2023 | $6,500,000 |
Crop Diagnostix is a biotechnology company that uses RNA sequencing and AI for predictive agriculture. | San Diego | CA | 2 - 10 | 2023 | $3,577,993 |
Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therap | South San Francisco | CA | 10 - 50 | 2023 | $178,000,000 |
Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | CA | 1 - 10 | 2023 | $8,700,000 | |
NeuroBionics is pioneering the future of precision bioelectronic medicine by inventing the next generation of implanted devices that will seamlessly interface with the human body. | Seattle | WA | 2 - 10 | 2023 | $11,000,000 |
Junevity is a biotech rewinding complex metabolic disease. Based on 6 years of breakthrough research at UCSF, Junevity's REWIND platform identifies high-level regulators of metabolic disease with known pharmacological pathways. Junevity is advancing multip | 1 - 10 | 2023 | $10,000,000 | ||
Kincell Bio collaborates with cell therapy developers by using considerable scientific experience and industry understanding. Transparency, accountability, and accuracy are essential to what makes us a reliable partner for process and analytical developmen | Gainesville | FL | 20 - 50 | 2023 | $36,000,000 |
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to- | San Francisco | CA | 20 - 50 | 2023 | $245,000,000 |
Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. | San Carlos | CA | 20 - 50 | 2022 | $70,029,888 |
Cell BioEngines, Inc., is a clinical-stage biotech company focused on curing cancer by developing ”off-the-shelf” allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical grade cells at scale. | New York | NY | 2 - 10 | 2022 | $1,375,000 |
Izote Biosciences is a software company currently based in Berkeley, California, United States. It has been founded in 2022 by Victor Reyes-Umana. | Berkeley | CA | 2 - 10 | 2022 | $2,600,000 |
Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment. | Newton | MA | 10 - 50 | 2022 | 100000000 CNY |
Guardian Bio is centred on developing a personalised cell therapy based on dendritic cells. | Boston | MA | 2 - 10 | 2022 | $500,000 |
Insamo offers the discovery of membrane-permeable & orally available cyclic-peptides which lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. | Berkeley | CA | 10 - 50 | 2022 | $12,000,000 |
Origin Endoscopy offers medical products to control the hemostatic effects of gastrointestinal bleeding during endoscopy procedures. | Englewood | CO | 2 - 10 | 2022 | $1,590,329 |
Wild Microbes is a next-generation microbial platform that makes everything from plastics to proteins. They develop new microbial strains, making scaling sustainable products faster and cheaper than ever. | Cambridge | MA | 2 - 10 | 2022 | $3,300,000 |
IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022. | Plymouth | MA | 20 - 50 | 2022 | $242,000,000 |
InduPro is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies. | Seattle | WA | 10 - 50 | 2022 | $85,000,000 |
Uniquity Bio operates as a drug development company. | Malvern | PA | 10 - 50 | 2022 | $300,000,000 |
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles | Cambridge | MA | 10 - 50 | 2022 | $128,000,000 |
OverT Bio operates as a biotech company that provide cell therapy for cancers.. The company's cell therapies identify and develop novel genetic modifications that will help immune cells overcome barriers created by tumors and lead to effective and durable | New York | NY | 2 - 10 | 2022 | $16,120,000 |
BiomEdit is an innovation company that discovers, designs, and develops novel probiotics, microbiome derived bioactives, and engineered microbial medicines to address unmet needs in animal health. Our ambition is to create solutions to some of the most imp | Fishers | IN | 20 - 50 | 2022 | $48,500,000 |
Amplexd Therapeutics focuses on the development of non-invasive, topical treatments aimed at addressing HPV-induced cervical dysplasia, a precursor to cervical cancer. The company's mission centers on providing accessible solutions to combat this public he | Gaithersburg | MD | 2 - 10 | 2022 | $2,000,000 |
Visiox is a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic therapeutic candidates to address highly prevalent diseases in need of new treatment options. | Tarrytown | NY | 2 - 10 | 2022 | $7,000,000 |
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Terragia Biofuel provides the technology to drive the next generation of biofuels. | Hanover | NH | 5 - 10 | 2022 | $6,000,000 |
Integrated Biosciences, Inc. is a biotechnology company. The Company combines synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases. Integrated Biosciences operates in the United States. | 2 - 10 | 2022 | $17,200,000 | ||
Systemic Bio is a 3D Systems company based in Houston, Texas, focused on the development of vascularized organ models made out of hydrogels and human cells to be used for drug discovery and development. | Houston | TX | 20 - 50 | 2022 | $15,000,000 |
Remepy is biotechnology research pioneering hybrid drugs. The company believes that in the future, software applications will become an integral part of treatments offered by Pharma companies in the form of Hybrid Drugs. These will include both a software | 10 - 50 | 2022 | $15,000,000 | ||
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 2 - 10 | 2022 | $6,999,999 |
RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted t | San Diego | CA | 5 - 10 | 2022 | $4,000,000 |
Lavo Life Sciences is an early-stage startup that creates drug development software tools. Lavo Life Sciences' AI-accelerated quantum chemistry methods make pharmaceutical property prediction less expensive and more robust than existing solutions. | San Francisco | CA | 2 - 10 | 2022 | $500,000 |
Vibe Bio is a community of patients, scientists, and partners committed to identifying, funding and developing promising treatments to rare diseases and empowering patient communities with unprecedented ownership over the process.Join us | Boston | MA | 5 - 20 | 2022 | $12,000,000 |
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented | Boston | MA | 5 - 20 | 2022 | $153,000,000 |
Via Scientific to help scientists and bioinformaticians generate novel science that improves the world. It was founded in 2022. | Cambridge | MA | 20 - 50 | 2022 | $5,000,000 |
Maverick BioMetals is a biotechnology business that is working to improve lithium processing. Founded in 2022 and is based in San Francisco, CA. | San Francisco | CA | 5 - 10 | 2022 | $10,143,534 |
Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DN | Boston | MA | 2 - 10 | 2022 | $1,800,000 |
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics. | Berkeley | CA | 5 - 20 | 2022 | $13,400,000 |
Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics. Cisterna Biologics uses proprietary technologies to build the next generation of mRNA. | Carlsbad | CA | 1 - 10 | 2022 | $500,000 |
Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic asthma. | Chapel Hill | NC | 10 - 50 | 2022 | $425,000,000 |
Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology. | Boston | MA | 10 - 50 | 2022 | $105,000,000 |
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders. | San Francisco | CA | 10 - 50 | 2022 | $94,000,000 |
Moonwalk Biosciences is a genomic medicine startup that aims to provide a new class of precision epigenetic therapeutics. The company is working on the development of a profiling and engineering technology platform that, with the help of advanced artificia | San Francisco | CA | 10 - 50 | 2022 | $57,000,000 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.